IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 46
Titolo Data di pubblicazione Autore(i) File
Repurposing opportunities for Parkinson’s disease therapies 1-gen-2017 Ambrosi, G.; Cerri, S.; Blandini, F.
Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat 1-gen-2017 Ambrosi, G.; Kustrimovic, N.; Siani, F.; Rasini, E.; Cerri, S.; Ghezzi, C.; Dicorato, G.; Caputo, S.; Marino, F.; Cosentino, M.; Blandini, F.
Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 1-gen-2017 Pellegrini, C.; Antonioli, L.; Colucci, R.; Tirotta, E.; Gentile, D.; Ippolito, C.; Segnani, C.; Levandis, G.; Cerri, S.; Blandini, F.; Barocelli, E.; Ballabeni, V.; Bernardini, N.; Blandizzi, C.; Fornai, M.
Activation of the CREB/c-Fos Pathway during Long-Term Synaptic Plasticity in the Cerebellum Granular Layer 1-gen-2017 Gandolfi, Daniela; Cerri, Silvia; Mapelli, Jonathan; Polimeni, Mariarosa; Tritto, Simona; Fuzzati Armentero, Marie Therese; Bigiani, Albertino; Blandini, Fabio; Mapelli, Lisa; D'Angelo, EGIDIO UGO
Investigational drugs in Phase I and Phase II for Levodopa-induced dyskinesias 1-gen-2017 Cerri, S.; Siani, F.; Blandini, F.
Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease 1-gen-2018 Milanese, C.; Cerri, S.; Ulusoy, A.; Gornati, S. V.; Plat, A.; Gabriels, S.; Blandini, F.; Di Monte, D. A.; Hoeijmakers, J. H.; Mastroberardino, P. G.
Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease 1-gen-2018 Milanese, C.; Cerri, S.; Ulusoy, A.; Gornati, S. V.; Plat, A.; Gabriels, S.; Blandini, F.; Di Monte, D. A.; Hoeijmakers, J. H.; Mastroberardino, P. G.
The exosomal/total α-synuclein ratio in plasma is associated with glucocerebrosidase activity and correlates with measures of disease severity in PD patients 1-gen-2018 Cerri, S.; Ghezzi, C.; Sampieri, M.; Siani, F.; Avenali, M.; Dornini, G.; Zangaglia, R.; Minafra, B.; Blandini, F.
In vivo imaging of early signs of dopaminergic neuronal death in an animal model of Parkinson's disease 1-gen-2018 Rizzi, N.; Brunialti, E.; Cerri, S.; Cermisoni, G.; Levandis, G.; Cesari, N.; Maggi, A.; Blandini, F.; Ciana, P.
Mitochondrial Complex i Reversible S-Nitrosation Improves Bioenergetics and Is Protective in Parkinson's Disease 1-gen-2018 Milanese, C.; Tapias, V.; Gabriels, S.; Cerri, S.; Levandis, G.; Blandini, F.; Tresini, M.; Shiva, S.; Greenamyre, J. T.; Gladwin, M. T.; Mastroberardino, P. G.
Development and biochemical characterization of a mouse model of Parkinson's disease bearing defective glucocerebrosidase activity 1-gen-2019 Mus, L.; Siani, F.; Giuliano, C.; Ghezzi, C.; Cerri, S.; Blandini, F.
Glucocerebrosidase mutations and synucleinopathies: Toward a model of precision medicine 1-gen-2019 Blandini, F.; Cilia, R.; Cerri, S.; Pezzoli, G.; Schapira, A. H. V.; Mullin, S.; Lanciego, J. L.
Role of autophagy in Parkinson’s disease 1-gen-2019 Cerri, S.; Blandini, F.
Peripheral-central neuroimmune crosstalk in parkinson’s disease: What do patients and animal models tell us? 1-gen-2019 Fuzzati-Armentero, M. T.; Cerri, S.; Blandini, F.
Parkinson's Disease in Women and Men: What's the Difference? 1-gen-2019 Cerri, S.; Mus, L.; Blandini, F.
In vivo modeling of prodromal stage of Parkinson's disease 1-gen-2020 Cerri, S.; Blandini, F.
Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s disease 1-gen-2020 Milanese, C.; Gabriels, S.; Barnhoorn, S.; Cerri, S.; Ulusoy, A.; Gornati, S. V.; Wallace, D. F.; Blandini, F.; Di Monte, D. A.; Subramaniam, V. N.; Mastroberardino, P. G.
An update on the use of non-ergot dopamine agonists for the treatment of Parkinson’s disease 1-gen-2020 Cerri, S.; Blandini, F.
Pathological remodelling of colonic wall following dopaminergic nigrostriatal neurodegeneration 1-gen-2020 Pellegrini, C.; Ippolito, C.; Segnani, C.; Dolfi, A.; Errede, M.; Virgintino, D.; Fornai, M.; Antonioli, L.; Garelli, F.; Nericcio, A.; Colucci, R.; Cerri, S.; Blandini, F.; Blandizzi, C.; Bernardini, N.
Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease 1-gen-2020 Avenali, M.; Blandini, F.; Cerri, S.
Mostrati risultati da 21 a 40 di 46
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile